Shattuck Labs Inc
STTK2.280USD
+0.050+2.24%
收盤 09/19, 16:00（美東）報價延遲15分鐘
109.22M總市值
虧損本益比TTM
關於 Shattuck Labs Inc 公司
Shattuck Labs, Inc. 是一家臨牀階段的生物技術公司。該公司致力於開發雙功能融合蛋白，作爲治療癌症和自身免疫性疾病患者的一類新型生物藥物。其主要候選產品 SL-172154 旨在同時抑制 CD47/SIRPa 巨噬細胞檢查點相互作用並激活 CD40 共刺激受體以誘導抗腫瘤免疫反應。該公司正在對急性髓系白血病 (AML) 和 HR-MDS 患者進行 IA/B 期臨牀試驗。該公司已完成該臨牀試驗的 IA 期劑量遞增部分，並正在招募 IB 期擴展隊列中的患者，評估 SL-172154 與阿扎胞苷聯合用於一線 HR-MDS 或一線 TP53 突變 (TP53m) AML 的療效。該公司開發了 ARC 平臺，以滿足對單一療法整合多種免疫功能的需求。
公司簡介
公司代碼STTK
公司名稱Shattuck Labs Inc
上市日期Oct 09, 2020
CEODr. Taylor Schreiber, M.D., Ph.D.
員工數量44
證券類型Ordinary Share
年結日Oct 09
公司地址500 W. 5Th Street
城市AUSTIN
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編78701
電話15129004690
網址https://www.shattucklabs.com/
公司代碼STTK
上市日期Oct 09, 2020
CEODr. Taylor Schreiber, M.D., Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
96.61K
+36.07%
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
86.28K
+17.43%
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
81.47K
-8.97%
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Ms. Helen M. Boudreau
Ms. Helen M. Boudreau
Independent Director
Independent Director
--
--
Mr. Conor Richardson, CPA
Mr. Conor Richardson, CPA
Senior Director, Finance & Investor Relations
Senior Director, Finance & Investor Relations
--
--
Dr. Clay Siegall, Ph.D.
Dr. Clay Siegall, Ph.D.
Independent Director
Independent Director
--
--
Mr. Andrew R. Neill
Mr. Andrew R. Neill
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Abhinav A. Shukla, Ph.D.
Dr. Abhinav A. Shukla, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
96.61K
+36.07%
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
86.28K
+17.43%
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
81.47K
-8.97%
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Ms. Helen M. Boudreau
Ms. Helen M. Boudreau
Independent Director
Independent Director
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 9月6日 週六
更新時間: 9月6日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Prosight Capital
13.86%
OrbiMed Advisors, LLC
13.16%
Redmile Group, LLC
11.56%
Adage Capital Management, L.P.
9.76%
Hornblower Capital Holdings, LLC
6.04%
其他
45.62%
持股股東
持股股東
佔比
Prosight Capital
13.86%
OrbiMed Advisors, LLC
13.16%
Redmile Group, LLC
11.56%
Adage Capital Management, L.P.
9.76%
Hornblower Capital Holdings, LLC
6.04%
其他
45.62%
股東類型
持股股東
佔比
Hedge Fund
28.47%
Investment Advisor/Hedge Fund
17.07%
Private Equity
13.16%
Corporation
12.56%
Investment Advisor
8.23%
Family Office
3.74%
Individual Investor
2.44%
Research Firm
1.52%
其他
12.81%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
186
35.33M
73.76%
-6.35M
2025Q1
190
36.10M
75.45%
-5.76M
2024Q4
182
37.00M
77.49%
-7.77M
2024Q3
191
41.87M
87.75%
-1.86M
2024Q2
194
39.66M
83.35%
+16.66K
2024Q1
209
37.10M
79.60%
-1.39M
2023Q4
203
34.54M
71.04%
+5.75M
2023Q3
205
27.35M
64.28%
-7.93M
2023Q2
215
27.61M
64.91%
-8.42M
2023Q1
223
27.26M
64.10%
-8.88M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Prosight Capital
6.64M
13.86%
--
--
Mar 31, 2025
Redmile Group, LLC
5.54M
11.56%
--
--
Mar 31, 2025
Adage Capital Management, L.P.
4.67M
9.76%
--
--
Mar 31, 2025
Hornblower Capital Holdings, LLC
2.89M
6.04%
--
--
Apr 01, 2025
Houghton Capital Holdings, LLC
2.61M
5.45%
--
--
Apr 01, 2025
The Vanguard Group, Inc.
2.40M
5.01%
-7.92K
-0.33%
Mar 31, 2025
The Clark Estates Inc.
1.48M
3.08%
--
--
Mar 31, 2025
Pinnacle Associates Ltd.
1.30M
2.71%
-25.00K
-1.89%
Mar 31, 2025
683 Capital Management LLC
1.05M
2.19%
--
--
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
